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EDITORIAL
Physicians have many responsibilities to their patients
first and foremost but also to other patients using the
same resources; to their colleagues; to the healthcare
system, towards society at large; to their students; and
not to be forgotten, to themselves, to maintain one’s
integrity by respecting one’s moral values. While those
duties are often prioritized in ethical and professional
codes such as the Code of Ethics of the Canadian
Medical Association (CMA) (1), many situations arise
in which the physician has to make a decision on
uncertain ethical grounds. Should an unconscious
patient be enrolled in a trial of a new, potentially life-
saving therapy without prior consent? Should patients
be exposed to the risks of having procedures performed
by students, under the justification of learning
opportunities to better serve the future? Should
physicians refuse to perform a procedure (e.g. abortion)
while knowing that the patient will likely undergo the
procedure illegally under unsafe conditions?
In the Crossroads section of this issue of the McGill
Journal of Medicine, we present two articles that foray
into controversial topics, where duties and
responsibilities of the physician seem to conflict. In
"Blood substitutes: the Polyheme Trials", the author
explores the controversy over the clinical trials of
Polyheme, an artificial blood substitute that has the
potential to revolutionize emergency pre-hospital care,
and to be a solution to the world-wide problem of blood
donations shortage. It is necessary to allow waiving of
patient consent for participation in a trial of emergency
treatment, but is it ethical? Should physicians follow a
utilitarian approach and make decisions for
incapacitated patients in the name of research and
potential benefits to the general population? The second
Crossroads article, “Paying Kidney Donors: Time to
Follow Iran?”, describes the converse situation: if a
patient wishes to undergo an operation to sell his or her
kidney, does the physician have a role in opposing such
a decision? If we bear the knowledge that those patients
will be facing great risks by selling their kidneys and
undergoing the transplant operation in the black market,
what is the physician’s duty in protecting these patients?
The Iranian model of kidney transplants offers financial
compensation and life-long healthcare coverage to
kidney donors, and is being credited for a significant
shortening of transplant waiting lists. The
objectification and commercialization of the human
body that it entails is however not considered ethically
acceptable by most medical associations in Western
Europe and North America (2, 3). In Canada, for
instance, the only living non-related donations that are
currently legally permitted are anonymous, voluntary,
and given to the public healthcare associations. In July
2006, the British Columbia Transplant Society in
association with the British Columbia branch of the
Kidney Society, was the first in North America to start
a pilot project of financial compensation of all living
kidney donors for the expenses associated with their
donations (4). Small steps are being taken in Canada
towards forming legislation allowing a government-
centered commercial donation system designed to
protect both donor and receiver, but it remains to be
seen if those projects will garner enough public support
and override the current ethical concerns.
Similarly to the issues we present in the Crossroads
section, the debate over the privatization of healthcare
in Canada is often centered on the duty of physicians to
patients: is it more important to serve everyone equally
or to improve global delivery of healthcare by reducing
the load on the present system, even if it entails positive
discrimination? In our Focus section we seek to provide
a balanced perspective of the ethical, social,
economical, and political implications of a possible
reform of the Canadian healthcare system. We have thus
invited two experts in the field, Dr. Edwin Coffey,
former President of the Quebec Medical Association
and Senior Fellow at the Montreal Economic Institute,
and Dr. Harvey Barkun, Officer of the Order of Canada,
member of the Rochon Commission and President of
the Society of Medical Administrators (USA), to
respectively discuss the arguments for and against
privatization. In addition, we have interviewed two
Quebec physicians, Dr. Paul Saba, family physician
practicing at the Lachine Hospital and the Médi-Centre
de Montréal-Ouest and Co-President of the Coalition of
Physicians for Social Justice, and Dr. Lawrence Stein,
Chief of the Division of Diagnostic Radiology at the
Royal Victoria Hospital (McGill University, Montreal,
Qc), to describe their respective experiences with public
or private realms of medicine. Lastly, two physicians
practicing abroad, Dr.Andrew Vallance-Owen, Medical
Director of the British United Provident Association,
and Dr. Hisayuki Hamada, Chief of Medical Education
at the National Nagasaki Medical Center (Japan),
described their respective countries’ health care
systems.
The current issue of the MJM intentionally raises
more questions than provides answers. We hope to
encourage students not only to conduct scientific
research, but also to participate in ethical debates. Since
one will often be confronted with difficult predicaments
in clinical practice with no clear right or wrong answers,
it is helpful for medical students to discuss abstract
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ethical and moral issues from the beginning of their
training in order to develop critical thinking skills. As
physicians of tomorrow, decisions will someday be ours
to make. It therefore becomes our duty, towards
ourselves and society at large, to reflect and to shape the
ethical cores that define our profession.
Regards,
AS, AYZ, YG
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